

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neurofilament cytoskeleton organization (GO:0060052) | 6.56947195 |
| 2 | negative regulation of dendrite morphogenesis (GO:0050774) | 5.75989797 |
| 3 | neuronal action potential propagation (GO:0019227) | 5.17161756 |
| 4 | cell migration in hindbrain (GO:0021535) | 5.11934719 |
| 5 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.02932344 |
| 6 | innervation (GO:0060384) | 4.96187287 |
| 7 | synaptic vesicle exocytosis (GO:0016079) | 4.86461039 |
| 8 | synaptic vesicle maturation (GO:0016188) | 4.85921226 |
| 9 | negative regulation of dendrite development (GO:2000171) | 4.74494602 |
| 10 | vocalization behavior (GO:0071625) | 4.67251682 |
| 11 | cell wall macromolecule catabolic process (GO:0016998) | 4.60379645 |
| 12 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.60310531 |
| 13 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 4.53349308 |
| 14 | neuron cell-cell adhesion (GO:0007158) | 4.42950755 |
| 15 | glutamate secretion (GO:0014047) | 4.41954405 |
| 16 | exploration behavior (GO:0035640) | 4.34459878 |
| 17 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.33936661 |
| 18 | detection of temperature stimulus (GO:0016048) | 4.15459488 |
| 19 | membrane depolarization during action potential (GO:0086010) | 4.14337286 |
| 20 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 4.12347155 |
| 21 | serotonin metabolic process (GO:0042428) | 4.07272479 |
| 22 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.06447602 |
| 23 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.05191894 |
| 24 | protein localization to synapse (GO:0035418) | 4.02689227 |
| 25 | regulation of synaptic vesicle transport (GO:1902803) | 4.01665298 |
| 26 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 3.95512331 |
| 27 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 3.95512331 |
| 28 | proline transport (GO:0015824) | 3.94870711 |
| 29 | regulation of NFAT protein import into nucleus (GO:0051532) | 3.93170739 |
| 30 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.91836619 |
| 31 | auditory behavior (GO:0031223) | 3.90905862 |
| 32 | cell wall macromolecule metabolic process (GO:0044036) | 3.90693137 |
| 33 | postsynaptic membrane organization (GO:0001941) | 3.89052423 |
| 34 | regulation of cell communication by electrical coupling (GO:0010649) | 3.81478005 |
| 35 | locomotory exploration behavior (GO:0035641) | 3.80526416 |
| 36 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.76517515 |
| 37 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.69283851 |
| 38 | nucleobase catabolic process (GO:0046113) | 3.69090051 |
| 39 | microtubule severing (GO:0051013) | 3.68364755 |
| 40 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.62730576 |
| 41 | neuromuscular process controlling posture (GO:0050884) | 3.61495867 |
| 42 | neurotransmitter secretion (GO:0007269) | 3.59397467 |
| 43 | presynaptic membrane assembly (GO:0097105) | 3.57575617 |
| 44 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.55728450 |
| 45 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.49388448 |
| 46 | primary amino compound metabolic process (GO:1901160) | 3.48015787 |
| 47 | peripheral nervous system neuron development (GO:0048935) | 3.47685679 |
| 48 | regulation of protein heterodimerization activity (GO:0043497) | 3.46374150 |
| 49 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.46284036 |
| 50 | negative regulation of microtubule polymerization (GO:0031115) | 3.45019490 |
| 51 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.40622309 |
| 52 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.40380869 |
| 53 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.40160837 |
| 54 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 3.37871909 |
| 55 | synaptic vesicle endocytosis (GO:0048488) | 3.37295796 |
| 56 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.33596991 |
| 57 | establishment of mitochondrion localization (GO:0051654) | 3.31184345 |
| 58 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.27403576 |
| 59 | mechanosensory behavior (GO:0007638) | 3.27220292 |
| 60 | mitochondrion transport along microtubule (GO:0047497) | 3.26585427 |
| 61 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.26585427 |
| 62 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.26054956 |
| 63 | neuron recognition (GO:0008038) | 3.24812303 |
| 64 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 3.20179067 |
| 65 | activation of protein kinase A activity (GO:0034199) | 3.18899319 |
| 66 | glutamate receptor signaling pathway (GO:0007215) | 3.18719509 |
| 67 | inositol phosphate catabolic process (GO:0071545) | 3.17559438 |
| 68 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.17453178 |
| 69 | neuronal action potential (GO:0019228) | 3.17380981 |
| 70 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.16657896 |
| 71 | layer formation in cerebral cortex (GO:0021819) | 3.16046145 |
| 72 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.15241920 |
| 73 | cellular potassium ion homeostasis (GO:0030007) | 3.14385651 |
| 74 | organelle transport along microtubule (GO:0072384) | 3.14261009 |
| 75 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.13768010 |
| 76 | positive regulation of muscle hypertrophy (GO:0014742) | 3.12683766 |
| 77 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 3.12683766 |
| 78 | synapse assembly (GO:0007416) | 3.11895608 |
| 79 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.11245431 |
| 80 | regulation of synapse structural plasticity (GO:0051823) | 3.10085808 |
| 81 | cochlea development (GO:0090102) | 3.05997895 |
| 82 | regulation of gene silencing by RNA (GO:0060966) | 3.05628675 |
| 83 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.05628675 |
| 84 | regulation of gene silencing by miRNA (GO:0060964) | 3.05628675 |
| 85 | neuromuscular process controlling balance (GO:0050885) | 3.05539036 |
| 86 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.04896739 |
| 87 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.04896739 |
| 88 | synaptic transmission, glutamatergic (GO:0035249) | 3.02066263 |
| 89 | cell communication by electrical coupling (GO:0010644) | 3.01926200 |
| 90 | presynaptic membrane organization (GO:0097090) | 3.01284219 |
| 91 | brain morphogenesis (GO:0048854) | 3.00015326 |
| 92 | neurotransmitter transport (GO:0006836) | 2.98179767 |
| 93 | vesicle transport along microtubule (GO:0047496) | 2.97756666 |
| 94 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.97330231 |
| 95 | cell communication involved in cardiac conduction (GO:0086065) | 2.96686673 |
| 96 | dendrite morphogenesis (GO:0048813) | 2.96529713 |
| 97 | activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171) | 2.96089264 |
| 98 | neuron-neuron synaptic transmission (GO:0007270) | 2.95374194 |
| 99 | membrane depolarization (GO:0051899) | 2.93717236 |
| 100 | resolution of meiotic recombination intermediates (GO:0000712) | 2.92430236 |
| 101 | negative regulation of sodium ion transport (GO:0010766) | 2.91064955 |
| 102 | ribonucleoprotein complex disassembly (GO:0032988) | 2.90399678 |
| 103 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.89693183 |
| 104 | axon cargo transport (GO:0008088) | 2.89359792 |
| 105 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.89243964 |
| 106 | acrosome reaction (GO:0007340) | 2.88839558 |
| 107 | regulation of vesicle fusion (GO:0031338) | 2.88120182 |
| 108 | regulation of synaptic plasticity (GO:0048167) | 2.87676631 |
| 109 | neuromuscular process (GO:0050905) | 2.86749625 |
| 110 | single strand break repair (GO:0000012) | 2.86091947 |
| 111 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.84862997 |
| 112 | striatum development (GO:0021756) | 2.84473754 |
| 113 | regulation of membrane repolarization (GO:0060306) | 2.84327957 |
| 114 | axonal fasciculation (GO:0007413) | 2.83505025 |
| 115 | negative regulation of cation channel activity (GO:2001258) | 2.81837687 |
| 116 | positive regulation of potassium ion transport (GO:0043268) | 2.81827947 |
| 117 | phosphorelay signal transduction system (GO:0000160) | 2.81234976 |
| 118 | transmission of nerve impulse (GO:0019226) | 2.81127645 |
| 119 | positive regulation of synapse maturation (GO:0090129) | 2.79857382 |
| 120 | response to auditory stimulus (GO:0010996) | 2.78334914 |
| 121 | startle response (GO:0001964) | 2.78038712 |
| 122 | atrial cardiac muscle cell action potential (GO:0086014) | 2.77419689 |
| 123 | gamma-aminobutyric acid transport (GO:0015812) | 2.77191305 |
| 124 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.76781968 |
| 125 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.76374879 |
| 126 | sympathetic nervous system development (GO:0048485) | 2.74764492 |
| 127 | cerebellar granule cell differentiation (GO:0021707) | 2.74035194 |
| 128 | social behavior (GO:0035176) | 2.73613633 |
| 129 | intraspecies interaction between organisms (GO:0051703) | 2.73613633 |
| 130 | positive regulation of vesicle fusion (GO:0031340) | 2.70647510 |
| 131 | acrosome assembly (GO:0001675) | 2.63356721 |
| 132 | positive regulation of microtubule polymerization or depolymerization (GO:0031112) | 2.63192825 |
| 133 | behavioral response to nicotine (GO:0035095) | 2.58459984 |
| 134 | regulation of centriole replication (GO:0046599) | 2.56043103 |
| 135 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.55659103 |
| 136 | retina layer formation (GO:0010842) | 2.51170564 |
| 137 | * homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156) | 2.50969960 |
| 138 | protein polyglutamylation (GO:0018095) | 2.50508404 |
| 139 | regulation of telomere maintenance (GO:0032204) | 2.49841624 |
| 140 | neurotransmitter uptake (GO:0001504) | 2.47828602 |
| 141 | axon extension (GO:0048675) | 2.47172703 |
| 142 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.45943635 |
| 143 | thalamus development (GO:0021794) | 2.45155875 |
| 144 | calcium ion-dependent exocytosis (GO:0017156) | 2.44734830 |
| 145 | coenzyme A biosynthetic process (GO:0015937) | 2.44428321 |
| 146 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.44000790 |
| 147 | dendrite development (GO:0016358) | 2.43872287 |
| 148 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.43713097 |
| 149 | positive regulation of synapse assembly (GO:0051965) | 2.35828029 |
| 150 | central nervous system neuron axonogenesis (GO:0021955) | 2.35323337 |
| 151 | nerve growth factor signaling pathway (GO:0038180) | 2.34650635 |
| 152 | regulation of neurotransmitter levels (GO:0001505) | 2.34200337 |
| 153 | hindbrain development (GO:0030902) | 2.33356231 |
| 154 | microtubule nucleation (GO:0007020) | 2.33264070 |
| 155 | regulation of synapse assembly (GO:0051963) | 2.32034004 |
| 156 | cranial nerve morphogenesis (GO:0021602) | 2.29795042 |
| 157 | neuron maturation (GO:0042551) | 2.29032693 |
| 158 | behavioral fear response (GO:0001662) | 2.28354786 |
| 159 | behavioral defense response (GO:0002209) | 2.28354786 |
| 160 | dendritic spine morphogenesis (GO:0060997) | 2.27433900 |
| 161 | behavioral response to ethanol (GO:0048149) | 2.27015243 |
| 162 | regulation of neuron migration (GO:2001222) | 2.25936089 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.28899566 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.14917168 |
| 3 | IGF1R_20145208_ChIP-Seq_DFB_Human | 3.18756864 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.15573270 |
| 5 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.15449725 |
| 6 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.97240991 |
| 7 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.88205835 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.75340387 |
| 9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.75340387 |
| 10 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.61078686 |
| 11 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.56932390 |
| 12 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.54039028 |
| 13 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.52814706 |
| 14 | FUS_26573619_Chip-Seq_HEK293_Human | 2.50290265 |
| 15 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.46902300 |
| 16 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.44159466 |
| 17 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.42834834 |
| 18 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.40463779 |
| 19 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.30043748 |
| 20 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.24802745 |
| 21 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.21251854 |
| 22 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.14377514 |
| 23 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.10520617 |
| 24 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.06573584 |
| 25 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.06164650 |
| 26 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.98281515 |
| 27 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.97757893 |
| 28 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.97733684 |
| 29 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.96839686 |
| 30 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.96839686 |
| 31 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.94326719 |
| 32 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.91140122 |
| 33 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.89258761 |
| 34 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.89214138 |
| 35 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.87417917 |
| 36 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.80072448 |
| 37 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.79087690 |
| 38 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.77639537 |
| 39 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.77345637 |
| 40 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.75417210 |
| 41 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.71352295 |
| 42 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.67783566 |
| 43 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.66347141 |
| 44 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.66250004 |
| 45 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.65002073 |
| 46 | P300_19829295_ChIP-Seq_ESCs_Human | 1.64743040 |
| 47 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.59227477 |
| 48 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.56020449 |
| 49 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.54070917 |
| 50 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.52017208 |
| 51 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.50652845 |
| 52 | EWS_26573619_Chip-Seq_HEK293_Human | 1.48207303 |
| 53 | AR_25329375_ChIP-Seq_VCAP_Human | 1.46611126 |
| 54 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.46392923 |
| 55 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.44934888 |
| 56 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.44677428 |
| 57 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.40903782 |
| 58 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.39317817 |
| 59 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.39116988 |
| 60 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.39116988 |
| 61 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.38001183 |
| 62 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.37340414 |
| 63 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.36845803 |
| 64 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.36423392 |
| 65 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.36420522 |
| 66 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.35785348 |
| 67 | STAT3_23295773_ChIP-Seq_U87_Human | 1.35354338 |
| 68 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.34876127 |
| 69 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.33737477 |
| 70 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.31520718 |
| 71 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.30989425 |
| 72 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.30097557 |
| 73 | AR_19668381_ChIP-Seq_PC3_Human | 1.26951613 |
| 74 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.26864229 |
| 75 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.26308517 |
| 76 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.25031636 |
| 77 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.23409727 |
| 78 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.21541273 |
| 79 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.21141614 |
| 80 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.19193716 |
| 81 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.16319978 |
| 82 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.15967894 |
| 83 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.14909040 |
| 84 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.13474507 |
| 85 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.12446541 |
| 86 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.12430983 |
| 87 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.11650263 |
| 88 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.11536917 |
| 89 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.11390990 |
| 90 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.10653087 |
| 91 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.09741916 |
| 92 | TCF4_23295773_ChIP-Seq_U87_Human | 1.09076479 |
| 93 | * TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.08728874 |
| 94 | * TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.08118275 |
| 95 | VDR_22108803_ChIP-Seq_LS180_Human | 1.08070015 |
| 96 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.06708006 |
| 97 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.05332117 |
| 98 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.05162140 |
| 99 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.04840903 |
| 100 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.04738534 |
| 101 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.03701846 |
| 102 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.03699007 |
| 103 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.03231716 |
| 104 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.02979223 |
| 105 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02711028 |
| 106 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.02701026 |
| 107 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.02125580 |
| 108 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.02104649 |
| 109 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.01854858 |
| 110 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.01523983 |
| 111 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.00083597 |
| 112 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.98382689 |
| 113 | JUN_21703547_ChIP-Seq_K562_Human | 0.97996702 |
| 114 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.97973313 |
| 115 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.97208018 |
| 116 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.96046203 |
| 117 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.96001320 |
| 118 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.95672030 |
| 119 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.95302338 |
| 120 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.94811668 |
| 121 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.93666897 |
| 122 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.93127603 |
| 123 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.93000346 |
| 124 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92088693 |
| 125 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.91196258 |
| 126 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.88912878 |
| 127 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.83708134 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004270_analgesia | 5.06442334 |
| 2 | MP0002735_abnormal_chemical_nociception | 4.82981634 |
| 3 | MP0004859_abnormal_synaptic_plasticity | 4.44828143 |
| 4 | MP0003880_abnormal_central_pattern | 3.97675030 |
| 5 | MP0006276_abnormal_autonomic_nervous | 3.89923369 |
| 6 | MP0001968_abnormal_touch/_nociception | 3.41097677 |
| 7 | MP0009046_muscle_twitch | 3.34891567 |
| 8 | MP0003635_abnormal_synaptic_transmissio | 3.29219526 |
| 9 | MP0002734_abnormal_mechanical_nocicepti | 3.25455920 |
| 10 | MP0002736_abnormal_nociception_after | 3.20245950 |
| 11 | MP0000569_abnormal_digit_pigmentation | 3.11906612 |
| 12 | MP0004858_abnormal_nervous_system | 2.93007717 |
| 13 | MP0002272_abnormal_nervous_system | 2.78943288 |
| 14 | MP0009745_abnormal_behavioral_response | 2.69403012 |
| 15 | MP0002733_abnormal_thermal_nociception | 2.68330257 |
| 16 | MP0002063_abnormal_learning/memory/cond | 2.66241628 |
| 17 | MP0002064_seizures | 2.53719912 |
| 18 | MP0002184_abnormal_innervation | 2.47218904 |
| 19 | MP0002572_abnormal_emotion/affect_behav | 2.33256052 |
| 20 | MP0001970_abnormal_pain_threshold | 2.29033167 |
| 21 | MP0001486_abnormal_startle_reflex | 2.23831868 |
| 22 | MP0002067_abnormal_sensory_capabilities | 2.19644692 |
| 23 | MP0002234_abnormal_pharynx_morphology | 2.01327884 |
| 24 | MP0005645_abnormal_hypothalamus_physiol | 1.93975161 |
| 25 | MP0004147_increased_porphyrin_level | 1.91766754 |
| 26 | MP0003329_amyloid_beta_deposits | 1.88558525 |
| 27 | MP0001501_abnormal_sleep_pattern | 1.79371614 |
| 28 | MP0008569_lethality_at_weaning | 1.78247106 |
| 29 | MP0002751_abnormal_autonomic_nervous | 1.77926354 |
| 30 | MP0000955_abnormal_spinal_cord | 1.75394551 |
| 31 | MP0000778_abnormal_nervous_system | 1.74322603 |
| 32 | MP0005423_abnormal_somatic_nervous | 1.73813749 |
| 33 | MP0003890_abnormal_embryonic-extraembry | 1.72645080 |
| 34 | MP0003121_genomic_imprinting | 1.69158367 |
| 35 | MP0004145_abnormal_muscle_electrophysio | 1.65162359 |
| 36 | MP0003879_abnormal_hair_cell | 1.61939043 |
| 37 | MP0001440_abnormal_grooming_behavior | 1.61205037 |
| 38 | MP0003937_abnormal_limbs/digits/tail_de | 1.59304198 |
| 39 | MP0001348_abnormal_lacrimal_gland | 1.58961143 |
| 40 | MP0004811_abnormal_neuron_physiology | 1.57796836 |
| 41 | MP0001984_abnormal_olfaction | 1.53288922 |
| 42 | MP0002557_abnormal_social/conspecific_i | 1.49808460 |
| 43 | MP0001986_abnormal_taste_sensitivity | 1.48734156 |
| 44 | MP0001188_hyperpigmentation | 1.47084083 |
| 45 | MP0004142_abnormal_muscle_tone | 1.44564818 |
| 46 | MP0003122_maternal_imprinting | 1.43639985 |
| 47 | MP0005386_behavior/neurological_phenoty | 1.41863632 |
| 48 | MP0004924_abnormal_behavior | 1.41863632 |
| 49 | MP0002638_abnormal_pupillary_reflex | 1.41005453 |
| 50 | MP0002882_abnormal_neuron_morphology | 1.40390922 |
| 51 | MP0002837_dystrophic_cardiac_calcinosis | 1.35670652 |
| 52 | MP0000579_abnormal_nail_morphology | 1.35027101 |
| 53 | MP0002066_abnormal_motor_capabilities/c | 1.34369538 |
| 54 | MP0002822_catalepsy | 1.33556034 |
| 55 | MP0002938_white_spotting | 1.32365817 |
| 56 | MP0003861_abnormal_nervous_system | 1.32050778 |
| 57 | MP0008057_abnormal_DNA_replication | 1.26880159 |
| 58 | MP0002909_abnormal_adrenal_gland | 1.25858043 |
| 59 | MP0009780_abnormal_chondrocyte_physiolo | 1.22215521 |
| 60 | MP0004133_heterotaxia | 1.21820824 |
| 61 | MP0005410_abnormal_fertilization | 1.21383392 |
| 62 | MP0004484_altered_response_of | 1.20895781 |
| 63 | MP0001529_abnormal_vocalization | 1.15888508 |
| 64 | MP0002229_neurodegeneration | 1.14924453 |
| 65 | MP0003633_abnormal_nervous_system | 1.14316840 |
| 66 | MP0002697_abnormal_eye_size | 1.14071247 |
| 67 | MP0004085_abnormal_heartbeat | 1.14044542 |
| 68 | MP0002102_abnormal_ear_morphology | 1.13178259 |
| 69 | MP0000537_abnormal_urethra_morphology | 1.12901624 |
| 70 | MP0000516_abnormal_urinary_system | 1.09799896 |
| 71 | MP0005367_renal/urinary_system_phenotyp | 1.09799896 |
| 72 | MP0005248_abnormal_Harderian_gland | 1.08495837 |
| 73 | MP0005646_abnormal_pituitary_gland | 1.06955587 |
| 74 | MP0003136_yellow_coat_color | 1.06192152 |
| 75 | MP0000372_irregular_coat_pigmentation | 1.05878092 |
| 76 | MP0000751_myopathy | 1.04256293 |
| 77 | MP0001905_abnormal_dopamine_level | 1.03915121 |
| 78 | MP0003631_nervous_system_phenotype | 1.03088230 |
| 79 | MP0001293_anophthalmia | 1.02696170 |
| 80 | MP0001963_abnormal_hearing_physiology | 1.02419939 |
| 81 | MP0000383_abnormal_hair_follicle | 1.02360638 |
| 82 | MP0005171_absent_coat_pigmentation | 1.00287299 |
| 83 | MP0003119_abnormal_digestive_system | 0.99248148 |
| 84 | MP0002752_abnormal_somatic_nervous | 0.98150488 |
| 85 | MP0001485_abnormal_pinna_reflex | 0.97645837 |
| 86 | MP0003634_abnormal_glial_cell | 0.96139149 |
| 87 | MP0003698_abnormal_male_reproductive | 0.95454665 |
| 88 | MP0000534_abnormal_ureter_morphology | 0.94567583 |
| 89 | MP0002233_abnormal_nose_morphology | 0.94406092 |
| 90 | MP0005535_abnormal_body_temperature | 0.93707578 |
| 91 | MP0000427_abnormal_hair_cycle | 0.93068218 |
| 92 | MP0000604_amyloidosis | 0.91757742 |
| 93 | MP0003787_abnormal_imprinting | 0.89628764 |
| 94 | MP0002152_abnormal_brain_morphology | 0.89514182 |
| 95 | MP0008874_decreased_physiological_sensi | 0.88845504 |
| 96 | MP0002653_abnormal_ependyma_morphology | 0.87159839 |
| 97 | MP0000920_abnormal_myelination | 0.86957393 |
| 98 | MP0008877_abnormal_DNA_methylation | 0.86599094 |
| 99 | MP0005394_taste/olfaction_phenotype | 0.86165218 |
| 100 | MP0005499_abnormal_olfactory_system | 0.86165218 |
| 101 | MP0000566_synostosis | 0.85034345 |
| 102 | MP0003183_abnormal_peptide_metabolism | 0.84380311 |
| 103 | MP0002081_perinatal_lethality | 0.82014071 |
| 104 | MP0003718_maternal_effect | 0.80300090 |
| 105 | MP0003935_abnormal_craniofacial_develop | 0.79383044 |
| 106 | MP0004742_abnormal_vestibular_system | 0.78785827 |
| 107 | MP0001177_atelectasis | 0.78656586 |
| 108 | MP0003632_abnormal_nervous_system | 0.76643360 |
| 109 | MP0003567_abnormal_fetal_cardiomyocyte | 0.76622120 |
| 110 | MP0009697_abnormal_copulation | 0.76556101 |
| 111 | MP0001324_abnormal_eye_pigmentation | 0.75880044 |
| 112 | MP0000049_abnormal_middle_ear | 0.74910630 |
| 113 | MP0008770_decreased_survivor_rate | 0.74570964 |
| 114 | MP0002082_postnatal_lethality | 0.74358244 |
| 115 | MP0010770_preweaning_lethality | 0.74358244 |
| 116 | MP0002069_abnormal_eating/drinking_beha | 0.73806973 |
| 117 | MP0003878_abnormal_ear_physiology | 0.73637912 |
| 118 | MP0005377_hearing/vestibular/ear_phenot | 0.73637912 |
| 119 | MP0005195_abnormal_posterior_eye | 0.72544664 |
| 120 | MP0001502_abnormal_circadian_rhythm | 0.70731700 |
| 121 | MP0005623_abnormal_meninges_morphology | 0.70641819 |
| 122 | MP0002876_abnormal_thyroid_physiology | 0.70599913 |
| 123 | MP0001299_abnormal_eye_distance/ | 0.70144544 |
| 124 | MP0003137_abnormal_impulse_conducting | 0.69836016 |
| 125 | MP0005551_abnormal_eye_electrophysiolog | 0.69795648 |
| 126 | MP0004885_abnormal_endolymph | 0.68435030 |
| 127 | MP0008775_abnormal_heart_ventricle | 0.67510541 |
| 128 | MP0004215_abnormal_myocardial_fiber | 0.61767766 |
| 129 | MP0001943_abnormal_respiration | 0.61610080 |
| 130 | MP0009379_abnormal_foot_pigmentation | 0.59944413 |
| 131 | MP0008789_abnormal_olfactory_epithelium | 0.58939858 |
| 132 | MP0003283_abnormal_digestive_organ | 0.58806532 |
| 133 | MP0004036_abnormal_muscle_relaxation | 0.58071079 |
| 134 | MP0004134_abnormal_chest_morphology | 0.57327418 |
| 135 | MP0000026_abnormal_inner_ear | 0.56817690 |
| 136 | MP0002972_abnormal_cardiac_muscle | 0.56013587 |
| 137 | MP0001919_abnormal_reproductive_system | 0.55365000 |
| 138 | MP0000631_abnormal_neuroendocrine_gland | 0.51440208 |
| 139 | MP0004883_abnormal_blood_vessel | 0.51150768 |
| 140 | MP0005166_decreased_susceptibility_to | 0.50662369 |
| 141 | MP0002160_abnormal_reproductive_system | 0.50374182 |
| 142 | MP0000538_abnormal_urinary_bladder | 0.49322633 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 6.91949709 |
| 2 | Focal motor seizures (HP:0011153) | 6.52416398 |
| 3 | Action tremor (HP:0002345) | 6.33481292 |
| 4 | Febrile seizures (HP:0002373) | 5.48692035 |
| 5 | Atonic seizures (HP:0010819) | 5.25312971 |
| 6 | Ulnar claw (HP:0001178) | 4.84360362 |
| 7 | Progressive cerebellar ataxia (HP:0002073) | 4.82099506 |
| 8 | Focal seizures (HP:0007359) | 4.64069110 |
| 9 | Insidious onset (HP:0003587) | 4.21190635 |
| 10 | Termporal pattern (HP:0011008) | 4.21190635 |
| 11 | Epileptic encephalopathy (HP:0200134) | 4.11739273 |
| 12 | Scanning speech (HP:0002168) | 3.99314722 |
| 13 | Absence seizures (HP:0002121) | 3.84792700 |
| 14 | Pheochromocytoma (HP:0002666) | 3.70278700 |
| 15 | Supranuclear gaze palsy (HP:0000605) | 3.51174487 |
| 16 | Generalized tonic-clonic seizures (HP:0002069) | 3.40321998 |
| 17 | Neuroendocrine neoplasm (HP:0100634) | 3.35842066 |
| 18 | Dialeptic seizures (HP:0011146) | 3.33887857 |
| 19 | Visual hallucinations (HP:0002367) | 3.33744660 |
| 20 | Truncal ataxia (HP:0002078) | 3.25870652 |
| 21 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.22960596 |
| 22 | Drooling (HP:0002307) | 3.21347742 |
| 23 | Genetic anticipation (HP:0003743) | 3.06830932 |
| 24 | Gaze-evoked nystagmus (HP:0000640) | 3.05441925 |
| 25 | Chronic hepatic failure (HP:0100626) | 3.04801380 |
| 26 | Hypothermia (HP:0002045) | 3.03514583 |
| 27 | Amblyopia (HP:0000646) | 2.89465009 |
| 28 | Abnormality of pain sensation (HP:0010832) | 2.88539947 |
| 29 | Impaired pain sensation (HP:0007328) | 2.88539947 |
| 30 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.87617610 |
| 31 | Excessive salivation (HP:0003781) | 2.87522190 |
| 32 | Ankle clonus (HP:0011448) | 2.84920484 |
| 33 | Urinary urgency (HP:0000012) | 2.81365615 |
| 34 | Hyperventilation (HP:0002883) | 2.80859546 |
| 35 | Spastic gait (HP:0002064) | 2.78245857 |
| 36 | Abnormality of the corticospinal tract (HP:0002492) | 2.75404123 |
| 37 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.74062666 |
| 38 | Failure to thrive in infancy (HP:0001531) | 2.70265012 |
| 39 | Impaired smooth pursuit (HP:0007772) | 2.69151137 |
| 40 | Delusions (HP:0000746) | 2.69111929 |
| 41 | Depression (HP:0000716) | 2.67125150 |
| 42 | Dysdiadochokinesis (HP:0002075) | 2.64370836 |
| 43 | Anxiety (HP:0000739) | 2.53812412 |
| 44 | Bifid tongue (HP:0010297) | 2.49977295 |
| 45 | Abnormal social behavior (HP:0012433) | 2.44905994 |
| 46 | Impaired social interactions (HP:0000735) | 2.44905994 |
| 47 | Colon cancer (HP:0003003) | 2.44575660 |
| 48 | Homocystinuria (HP:0002156) | 2.43235827 |
| 49 | Abnormality of homocysteine metabolism (HP:0010919) | 2.43235827 |
| 50 | Nephronophthisis (HP:0000090) | 2.41897537 |
| 51 | Dysmetric saccades (HP:0000641) | 2.39499527 |
| 52 | Abnormality of the lower motor neuron (HP:0002366) | 2.39467179 |
| 53 | Apathy (HP:0000741) | 2.39218108 |
| 54 | Retinal dysplasia (HP:0007973) | 2.38349202 |
| 55 | Hammertoe (HP:0001765) | 2.38079617 |
| 56 | Molar tooth sign on MRI (HP:0002419) | 2.36629255 |
| 57 | Abnormality of midbrain morphology (HP:0002418) | 2.36629255 |
| 58 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.35995833 |
| 59 | Aplasia of the phalanges of the hand (HP:0009802) | 2.35995833 |
| 60 | Aplasia involving bones of the extremities (HP:0009825) | 2.35995833 |
| 61 | Papillary thyroid carcinoma (HP:0002895) | 2.35792798 |
| 62 | Gait imbalance (HP:0002141) | 2.35722057 |
| 63 | Menstrual irregularities (HP:0000858) | 2.33452348 |
| 64 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 2.33037715 |
| 65 | Ventricular fibrillation (HP:0001663) | 2.30494863 |
| 66 | Hepatoblastoma (HP:0002884) | 2.29424765 |
| 67 | Cerebellar dysplasia (HP:0007033) | 2.29043346 |
| 68 | Dysmetria (HP:0001310) | 2.29022576 |
| 69 | Poor coordination (HP:0002370) | 2.25781455 |
| 70 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.22854895 |
| 71 | Hypoplasia of the brainstem (HP:0002365) | 2.22854895 |
| 72 | Inability to walk (HP:0002540) | 2.21994783 |
| 73 | Poor eye contact (HP:0000817) | 2.21361831 |
| 74 | Pancreatic fibrosis (HP:0100732) | 2.16163069 |
| 75 | Vitreoretinal degeneration (HP:0000655) | 2.16068780 |
| 76 | Fetal akinesia sequence (HP:0001989) | 2.15675206 |
| 77 | Impaired vibratory sensation (HP:0002495) | 2.15501643 |
| 78 | Bradycardia (HP:0001662) | 2.14860798 |
| 79 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.13480875 |
| 80 | Esophageal atresia (HP:0002032) | 2.12941122 |
| 81 | Epileptiform EEG discharges (HP:0011182) | 2.12720547 |
| 82 | Fibular aplasia (HP:0002990) | 2.12308389 |
| 83 | Abnormal eating behavior (HP:0100738) | 2.11176068 |
| 84 | Vaginal atresia (HP:0000148) | 2.10997250 |
| 85 | Short tibia (HP:0005736) | 2.09499471 |
| 86 | Akinesia (HP:0002304) | 2.08801573 |
| 87 | Amyotrophic lateral sclerosis (HP:0007354) | 2.08504213 |
| 88 | Optic nerve hypoplasia (HP:0000609) | 2.07550194 |
| 89 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.06744281 |
| 90 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.06600634 |
| 91 | Genital tract atresia (HP:0001827) | 2.06182530 |
| 92 | Limb dystonia (HP:0002451) | 2.05632403 |
| 93 | Esotropia (HP:0000565) | 2.05427294 |
| 94 | Bradykinesia (HP:0002067) | 2.04798150 |
| 95 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.03840154 |
| 96 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.03840154 |
| 97 | Diminished motivation (HP:0000745) | 2.03472104 |
| 98 | Broad-based gait (HP:0002136) | 2.02722468 |
| 99 | EEG with generalized epileptiform discharges (HP:0011198) | 2.02702856 |
| 100 | Nephrogenic diabetes insipidus (HP:0009806) | 2.02201240 |
| 101 | Lower limb muscle weakness (HP:0007340) | 2.02165820 |
| 102 | Congenital primary aphakia (HP:0007707) | 2.01578251 |
| 103 | Steppage gait (HP:0003376) | 2.01385135 |
| 104 | Decreased motor nerve conduction velocity (HP:0003431) | 2.00822155 |
| 105 | Lissencephaly (HP:0001339) | 2.00140376 |
| 106 | Postural instability (HP:0002172) | 1.99774480 |
| 107 | Foot dorsiflexor weakness (HP:0009027) | 1.98772776 |
| 108 | Intellectual disability, moderate (HP:0002342) | 1.98520508 |
| 109 | Generalized hypotonia (HP:0001290) | 1.97519782 |
| 110 | Chorioretinal atrophy (HP:0000533) | 1.97373929 |
| 111 | Occipital encephalocele (HP:0002085) | 1.95295823 |
| 112 | Renovascular hypertension (HP:0100817) | 1.94643710 |
| 113 | Hypercortisolism (HP:0001578) | 1.92422449 |
| 114 | Absent speech (HP:0001344) | 1.92369884 |
| 115 | Protruding tongue (HP:0010808) | 1.91890974 |
| 116 | Hypsarrhythmia (HP:0002521) | 1.91644373 |
| 117 | Dysautonomia (HP:0002459) | 1.91291564 |
| 118 | Exotropia (HP:0000577) | 1.91209467 |
| 119 | Midline defect of the nose (HP:0004122) | 1.90503904 |
| 120 | Hypoventilation (HP:0002791) | 1.89851588 |
| 121 | Reticulocytopenia (HP:0001896) | 1.88983431 |
| 122 | Distal sensory impairment (HP:0002936) | 1.88628732 |
| 123 | Agitation (HP:0000713) | 1.87491955 |
| 124 | Astrocytoma (HP:0009592) | 1.86460754 |
| 125 | Abnormality of the astrocytes (HP:0100707) | 1.86460754 |
| 126 | Torticollis (HP:0000473) | 1.86046107 |
| 127 | Anosmia (HP:0000458) | 1.85016415 |
| 128 | Thyroid carcinoma (HP:0002890) | 1.84838529 |
| 129 | Abnormality of the renal medulla (HP:0100957) | 1.83026539 |
| 130 | Hemiparesis (HP:0001269) | 1.82244675 |
| 131 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.81038351 |
| 132 | Medial flaring of the eyebrow (HP:0010747) | 1.80452838 |
| 133 | Cutaneous finger syndactyly (HP:0010554) | 1.79829935 |
| 134 | Submucous cleft hard palate (HP:0000176) | 1.78864517 |
| 135 | Hemiplegia (HP:0002301) | 1.78831976 |
| 136 | Abnormality of saccadic eye movements (HP:0000570) | 1.78672831 |
| 137 | Specific learning disability (HP:0001328) | 1.77729585 |
| 138 | Type II lissencephaly (HP:0007260) | 1.77251860 |
| 139 | Autoamputation (HP:0001218) | 1.76007638 |
| 140 | True hermaphroditism (HP:0010459) | 1.74907878 |
| 141 | Restlessness (HP:0000711) | 1.72083047 |
| 142 | Intellectual disability, severe (HP:0010864) | 1.71633059 |
| 143 | Anencephaly (HP:0002323) | 1.71167890 |
| 144 | Cutaneous syndactyly (HP:0012725) | 1.69355971 |
| 145 | Epidermoid cyst (HP:0200040) | 1.68793679 |
| 146 | Abnormality of the pubic bones (HP:0003172) | 1.68641994 |
| 147 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.67781048 |
| 148 | Impulsivity (HP:0100710) | 1.67058804 |
| 149 | Poor suck (HP:0002033) | 1.66838231 |
| 150 | Partial duplication of thumb phalanx (HP:0009944) | 1.65242946 |
| 151 | Abnormality of salivation (HP:0100755) | 1.64875964 |
| 152 | Narrow forehead (HP:0000341) | 1.64466646 |
| 153 | Progressive inability to walk (HP:0002505) | 1.61942128 |
| 154 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.60931317 |
| 155 | Glioma (HP:0009733) | 1.60691721 |
| 156 | Absent eyebrow (HP:0002223) | 1.60349496 |
| 157 | Tubulointerstitial nephritis (HP:0001970) | 1.60265136 |
| 158 | Neoplasm of the adrenal cortex (HP:0100641) | 1.59685690 |
| 159 | Pancreatic cysts (HP:0001737) | 1.59087272 |
| 160 | Obsessive-compulsive behavior (HP:0000722) | 1.58266955 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 5.19672080 |
| 2 | CASK | 4.06895040 |
| 3 | MINK1 | 3.65700177 |
| 4 | MAP3K4 | 3.03661478 |
| 5 | MAP3K9 | 2.93894703 |
| 6 | WNK3 | 2.84976929 |
| 7 | MAP2K7 | 2.68142637 |
| 8 | SRPK1 | 2.35364660 |
| 9 | NTRK1 | 2.35098987 |
| 10 | MAP3K12 | 2.31596991 |
| 11 | STK38L | 2.22535518 |
| 12 | BRD4 | 2.15641871 |
| 13 | LMTK2 | 2.15632471 |
| 14 | MARK1 | 2.10761774 |
| 15 | MAP2K4 | 2.09765206 |
| 16 | LATS1 | 2.01521621 |
| 17 | PLK2 | 1.92629155 |
| 18 | EPHA4 | 1.87931900 |
| 19 | MAPK13 | 1.85185819 |
| 20 | CAMK1G | 1.77367097 |
| 21 | TRIM28 | 1.77364313 |
| 22 | TYRO3 | 1.68653976 |
| 23 | SGK2 | 1.59649207 |
| 24 | RIPK1 | 1.57668949 |
| 25 | AKT3 | 1.52920406 |
| 26 | KSR2 | 1.49849183 |
| 27 | PAK6 | 1.49738049 |
| 28 | CAMK1D | 1.46607297 |
| 29 | SGK494 | 1.45503131 |
| 30 | SGK223 | 1.45503131 |
| 31 | ZAK | 1.44448233 |
| 32 | PLK4 | 1.39017415 |
| 33 | MKNK2 | 1.37247853 |
| 34 | BRSK2 | 1.36651961 |
| 35 | CDK5 | 1.36357692 |
| 36 | PRKCG | 1.35562682 |
| 37 | RIPK4 | 1.34731728 |
| 38 | LATS2 | 1.34020585 |
| 39 | PHKG1 | 1.32120751 |
| 40 | PHKG2 | 1.32120751 |
| 41 | TESK1 | 1.26494912 |
| 42 | DAPK2 | 1.24123882 |
| 43 | CDC7 | 1.16370889 |
| 44 | CCNB1 | 1.11229292 |
| 45 | GRK5 | 1.10462802 |
| 46 | WNK1 | 1.10400823 |
| 47 | UHMK1 | 1.10275465 |
| 48 | DAPK1 | 1.09648358 |
| 49 | SGK3 | 1.08574586 |
| 50 | TNK2 | 1.06340032 |
| 51 | CSNK1G1 | 1.04426456 |
| 52 | FRK | 1.04350642 |
| 53 | MAP3K2 | 1.03550605 |
| 54 | KSR1 | 1.02582320 |
| 55 | WEE1 | 1.01659286 |
| 56 | BMPR1B | 1.01620019 |
| 57 | GRK7 | 0.97910911 |
| 58 | SCYL2 | 0.97228347 |
| 59 | MAP3K5 | 0.95588900 |
| 60 | PDPK1 | 0.95556084 |
| 61 | CSNK1G3 | 0.94645739 |
| 62 | INSRR | 0.93602683 |
| 63 | SIK3 | 0.91418643 |
| 64 | FGFR2 | 0.90451200 |
| 65 | CSNK1A1L | 0.90057517 |
| 66 | CAMK2A | 0.89922055 |
| 67 | PDK1 | 0.89520911 |
| 68 | CAMKK1 | 0.88633823 |
| 69 | NTRK2 | 0.87602786 |
| 70 | PNCK | 0.86066622 |
| 71 | MELK | 0.85617452 |
| 72 | PRKCH | 0.84045249 |
| 73 | CDK3 | 0.83239765 |
| 74 | ARAF | 0.83181948 |
| 75 | RET | 0.80460640 |
| 76 | TSSK6 | 0.80354795 |
| 77 | MAP4K2 | 0.79942486 |
| 78 | MAPKAPK3 | 0.79381543 |
| 79 | BMPR2 | 0.79035343 |
| 80 | MAP2K1 | 0.78516407 |
| 81 | CDK19 | 0.77252590 |
| 82 | CDK18 | 0.76084425 |
| 83 | DYRK1A | 0.74823222 |
| 84 | CAMKK2 | 0.74528845 |
| 85 | CSNK1G2 | 0.74030024 |
| 86 | CDK14 | 0.73148550 |
| 87 | ERBB3 | 0.72752612 |
| 88 | SGK1 | 0.71897429 |
| 89 | PRPF4B | 0.71534934 |
| 90 | NEK6 | 0.71269562 |
| 91 | NEK9 | 0.69173604 |
| 92 | MAP3K10 | 0.68731763 |
| 93 | CDK15 | 0.68188447 |
| 94 | TNIK | 0.67598250 |
| 95 | MATK | 0.67232293 |
| 96 | MET | 0.66935573 |
| 97 | SIK2 | 0.66671106 |
| 98 | EPHB2 | 0.66267001 |
| 99 | RPS6KA2 | 0.66055742 |
| 100 | PINK1 | 0.65877066 |
| 101 | BRAF | 0.65867663 |
| 102 | ADRBK1 | 0.65169371 |
| 103 | BRSK1 | 0.64931742 |
| 104 | EPHA3 | 0.64662601 |
| 105 | STK39 | 0.61350883 |
| 106 | JAK1 | 0.60422425 |
| 107 | FER | 0.59793824 |
| 108 | CDK11A | 0.59627699 |
| 109 | PIK3CA | 0.59626206 |
| 110 | ERBB4 | 0.57990689 |
| 111 | CAMK4 | 0.57243440 |
| 112 | PTK2B | 0.56248028 |
| 113 | MAP3K6 | 0.56099825 |
| 114 | FES | 0.56084761 |
| 115 | TAF1 | 0.56027099 |
| 116 | LIMK1 | 0.55677468 |
| 117 | CAMK2B | 0.55578152 |
| 118 | CAMK2D | 0.54862197 |
| 119 | WNK4 | 0.54315297 |
| 120 | MKNK1 | 0.53938266 |
| 121 | ROCK2 | 0.53789729 |
| 122 | MAP3K1 | 0.52892410 |
| 123 | PRKCE | 0.51128408 |
| 124 | RPS6KB1 | 0.50724112 |
| 125 | CAMK1 | 0.50230650 |
| 126 | CAMK2G | 0.49997768 |
| 127 | PAK3 | 0.49686277 |
| 128 | CSNK1E | 0.49585618 |
| 129 | TTK | 0.49417954 |
| 130 | DYRK2 | 0.49348042 |
| 131 | OXSR1 | 0.48911971 |
| 132 | RPS6KA4 | 0.48680544 |
| 133 | PRKAA1 | 0.48448851 |
| 134 | STK38 | 0.48344074 |
| 135 | MARK2 | 0.47307428 |
| 136 | CSNK1D | 0.46952049 |
| 137 | ATM | 0.46461056 |
| 138 | PRKCZ | 0.46331981 |
| 139 | RPS6KA3 | 0.45932742 |
| 140 | BCR | 0.45899174 |
| 141 | PDK3 | 0.45780742 |
| 142 | PDK4 | 0.45780742 |
| 143 | PRKD3 | 0.44495592 |
| 144 | PRKG1 | 0.44412545 |
| 145 | DYRK3 | 0.44179716 |
| 146 | MAP3K13 | 0.43681074 |
| 147 | FGR | 0.43313326 |
| 148 | NEK1 | 0.43145574 |
| 149 | PRKCI | 0.43049178 |
| 150 | ADRBK2 | 0.42840489 |
| 151 | PLK1 | 0.42677053 |
| 152 | STK24 | 0.42426995 |
| 153 | PRKACB | 0.41635900 |
| 154 | PKN1 | 0.41485658 |
| 155 | GRK1 | 0.40037103 |
| 156 | STK3 | 0.39981510 |
| 157 | MST1R | 0.39717234 |
| 158 | GSK3B | 0.37624676 |
| 159 | ICK | 0.35407626 |
| 160 | PRKDC | 0.34079190 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.52720651 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.28854497 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.87233019 |
| 4 | Long-term potentiation_Homo sapiens_hsa04720 | 2.63965402 |
| 5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.48458088 |
| 6 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 2.45565360 |
| 7 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.45025036 |
| 8 | Circadian entrainment_Homo sapiens_hsa04713 | 2.39321812 |
| 9 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.35647393 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.33057045 |
| 11 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.28657646 |
| 12 | GABAergic synapse_Homo sapiens_hsa04727 | 2.25940998 |
| 13 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 2.21083160 |
| 14 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.12189623 |
| 15 | Insulin secretion_Homo sapiens_hsa04911 | 1.99048979 |
| 16 | Taste transduction_Homo sapiens_hsa04742 | 1.97629987 |
| 17 | Morphine addiction_Homo sapiens_hsa05032 | 1.95972726 |
| 18 | Salivary secretion_Homo sapiens_hsa04970 | 1.88544633 |
| 19 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.83787061 |
| 20 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.83763331 |
| 21 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.83459971 |
| 22 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.74704820 |
| 23 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.72251715 |
| 24 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.67367741 |
| 25 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.65748736 |
| 26 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.64177883 |
| 27 | Renin secretion_Homo sapiens_hsa04924 | 1.60438611 |
| 28 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.55189795 |
| 29 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.53662222 |
| 30 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.50151824 |
| 31 | Basal transcription factors_Homo sapiens_hsa03022 | 1.38930543 |
| 32 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.38596873 |
| 33 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.37830831 |
| 34 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.34661071 |
| 35 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.32246789 |
| 36 | Long-term depression_Homo sapiens_hsa04730 | 1.28263402 |
| 37 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.27622666 |
| 38 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.24212514 |
| 39 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.21207053 |
| 40 | Gap junction_Homo sapiens_hsa04540 | 1.20581141 |
| 41 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.18165041 |
| 42 | Cocaine addiction_Homo sapiens_hsa05030 | 1.17430649 |
| 43 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.14453133 |
| 44 | Axon guidance_Homo sapiens_hsa04360 | 1.14111422 |
| 45 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.12491685 |
| 46 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.07768864 |
| 47 | Glioma_Homo sapiens_hsa05214 | 1.05075724 |
| 48 | Tight junction_Homo sapiens_hsa04530 | 1.04714232 |
| 49 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.03598202 |
| 50 | Phototransduction_Homo sapiens_hsa04744 | 1.02567643 |
| 51 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.01850071 |
| 52 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.01785004 |
| 53 | Alzheimers disease_Homo sapiens_hsa05010 | 1.01686506 |
| 54 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.01476524 |
| 55 | Melanogenesis_Homo sapiens_hsa04916 | 1.00571112 |
| 56 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.00188425 |
| 57 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.98156005 |
| 58 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.96001238 |
| 59 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.95260063 |
| 60 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.92842853 |
| 61 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.92660702 |
| 62 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.92595313 |
| 63 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.90030702 |
| 64 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.89924611 |
| 65 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.87034018 |
| 66 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.86570444 |
| 67 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.85642931 |
| 68 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.84172496 |
| 69 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.83609315 |
| 70 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.82825064 |
| 71 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.82443488 |
| 72 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.80467316 |
| 73 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.80424235 |
| 74 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.80048230 |
| 75 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.76008391 |
| 76 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.75877734 |
| 77 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.74647851 |
| 78 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.74474749 |
| 79 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.73882134 |
| 80 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.73874883 |
| 81 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.72127282 |
| 82 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.72124483 |
| 83 | Parkinsons disease_Homo sapiens_hsa05012 | 0.71290651 |
| 84 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.69709647 |
| 85 | Protein export_Homo sapiens_hsa03060 | 0.68821760 |
| 86 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.64200608 |
| 87 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.64193348 |
| 88 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.61952497 |
| 89 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.61357145 |
| 90 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.60989965 |
| 91 | Histidine metabolism_Homo sapiens_hsa00340 | 0.60726553 |
| 92 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.59535423 |
| 93 | RNA transport_Homo sapiens_hsa03013 | 0.58920303 |
| 94 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.55696956 |
| 95 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.55234313 |
| 96 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.55181966 |
| 97 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.55174797 |
| 98 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.53305777 |
| 99 | Bile secretion_Homo sapiens_hsa04976 | 0.51263862 |
| 100 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.50869041 |
| 101 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.50022316 |
| 102 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.48246153 |
| 103 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.47746077 |
| 104 | Phagosome_Homo sapiens_hsa04145 | 0.46560785 |
| 105 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.46343316 |
| 106 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.45988157 |
| 107 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.45340855 |
| 108 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.44662872 |
| 109 | Adherens junction_Homo sapiens_hsa04520 | 0.43578757 |
| 110 | Prion diseases_Homo sapiens_hsa05020 | 0.42248670 |
| 111 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.41916973 |
| 112 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.41139072 |
| 113 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.41104558 |
| 114 | Huntingtons disease_Homo sapiens_hsa05016 | 0.40673267 |
| 115 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.40474703 |
| 116 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.39728797 |
| 117 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.39344477 |
| 118 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.39155814 |
| 119 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.36432529 |
| 120 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.36161553 |
| 121 | Endometrial cancer_Homo sapiens_hsa05213 | 0.35329524 |
| 122 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.35072253 |
| 123 | Salmonella infection_Homo sapiens_hsa05132 | 0.34481451 |
| 124 | Thyroid cancer_Homo sapiens_hsa05216 | 0.33856401 |
| 125 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.33500749 |
| 126 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.32994154 |
| 127 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.32843990 |
| 128 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.32255358 |
| 129 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.32147293 |
| 130 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.32119542 |
| 131 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.30731944 |
| 132 | Melanoma_Homo sapiens_hsa05218 | 0.30192283 |
| 133 | Alcoholism_Homo sapiens_hsa05034 | 0.29861848 |
| 134 | Endocytosis_Homo sapiens_hsa04144 | 0.29647700 |
| 135 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.29539608 |
| 136 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.29089265 |
| 137 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.28620818 |
| 138 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.27786079 |
| 139 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.26096981 |
| 140 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.25606867 |

